ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Notable Labs Ltd

Notable Labs Ltd (NTBL)

0.2479
0.00
(0.00%)
Closed December 17 3:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.2479
Bid
0.2456
Ask
0.2498
Volume
-
0.00 Day's Range 0.00
0.22 52 Week Range 3.13
Market Cap
Previous Close
0.2479
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
2,737,208
Shares Outstanding
9,659,496
Dividend Yield
-
PE Ratio
-0.21
Earnings Per Share (EPS)
-1.17
Revenue
310k
Net Profit
-11.26M

About Notable Labs Ltd

Vascular Biogenics Ltd. is a clinical stage biotechnology company engaged in the discovery, development, and commercialization of novel treatments for cancer and immune-inflammatory diseases. Vascular Biogenics Ltd. is a clinical stage biotechnology company engaged in the discovery, development, and commercialization of novel treatments for cancer and immune-inflammatory diseases.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Modi'in-maccabim-re'ut, Center, Isr
Founded
-
Notable Labs Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NTBL. The last closing price for Notable Labs was US$0.25. Over the last year, Notable Labs shares have traded in a share price range of US$ 0.22 to US$ 3.13.

Notable Labs currently has 9,659,496 shares outstanding. The market capitalization of Notable Labs is US$2.39 million. Notable Labs has a price to earnings ratio (PE ratio) of -0.21.

NTBL Latest News

Notable Labs Donates $60,000 to MDS Foundation to Accelerate Progress for Patients with Myelodysplastic Syndromes

Notable Labs Donates $60,000 to MDS Foundation to Accelerate Progress for Patients with Myelodysplastic Syndromes PR Newswire SAN DIEGO, Dec. 13, 2023 Funds will help advance MDS Education...

Notable Labs Funds Myelodysplastic Syndromes Foundation with $60,000 Grant

Notable Labs Funds Myelodysplastic Syndromes Foundation with $60,000 Grant PR Newswire SAN DIEGO, Dec. 11, 2023 Funds will help advance MDS Education, Advocacy and Research SAN DIEGO, Dec. 11...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.24790.24790.247900CS
4000.24790.24790.247900CS
12-0.2061-45.39647577090.4540.66580.2227372080.36947922CS
26-0.4721-65.56944444440.720.8080.2213186430.3779505CS
52-2.7021-91.59661016952.953.130.228166170.55414333CS
156-4.2521-94.49111111114.55.270.227043030.58593052CS
260-4.2521-94.49111111114.55.270.227043030.58593052CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUKKNukkleus Inc
US$ 11.655
(738.49%)
174.4M
PRTGPortage Biotech Inc
US$ 8.8678
(172.86%)
36.61M
OPTXSyntec Optics Holdings Inc
US$ 3.55
(99.44%)
93.16M
PTPIPetros Pharmaceuticals Inc
US$ 0.4976
(86.37%)
63.49M
LUXHLuxUrban Hotels Inc
US$ 0.849899
(59.67%)
29.52M
VCNXVaccinex Inc
US$ 1.41
(-61.37%)
758.95k
TNYATenaya Therapeutics Inc
US$ 1.395
(-51.56%)
42.45M
ORKTOrangeKloud Technology Inc
US$ 2.14
(-41.85%)
2.29M
RVPHReviva Pharmaceuticals Holdings Inc
US$ 1.395
(-39.35%)
18.16M
DBGIDigital Brands Group Inc
US$ 2.46
(-37.88%)
805.23k
RIMEAlgorhythm Holdings Inc
US$ 0.0877
(8.27%)
1.13B
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.335
(-36.79%)
1.02B
GOEVCanoo Inc
US$ 0.118
(7.08%)
388.43M
NVDANVIDIA Corporation
US$ 130.39
(-1.22%)
259.4M
XTIAXTI Aerospace Inc
US$ 0.0442
(8.33%)
222.55M

NTBL Discussion

View Posts
hondaboost hondaboost 4 days ago
NTBLQ: Warning! Limited Information, will be Cancelled soon!

OTC Markets Group has confirmed that this company has limited disclosure or financial information publicly available, but meets a minimum requirement for public quoting under Rule 15c2-11. The Pink Limited Information tier may include companies that are delinquent in their filing obligations with the SEC, a foreign exchange or regulator, or under the Pink Disclosure Guidelines, as well as non-U.S. companies listed on a foreign exchange that does not require English disclosure and do not certify their compliance with SEC Rule 12g3-2(b).
👍️0
Renee Renee 2 months ago
NTBL changed to NTBLQ, bankruptcy. Delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions
👍️0
zj3001 zj3001 2 months ago
Is this ready to pop?
👍️0
glenn1919 glenn1919 2 months ago
NTBL.......................................https://stockcharts.com/h-sc/ui?s=NTBL&p=W&b=5&g=0&id=p86431144783
👍️0
Awl416 Awl416 2 months ago
That move made sense LOL…OTC Oct 23rd
👍 1
willlbone willlbone 2 months ago
PPMP and Dump.
👍️0
TheFinalCD TheFinalCD 2 months ago
https://ih.advfn.com/stock-market/NASDAQ/notable-labs-NTBL/stock-news/94717029/form-8-k-current-report
👍️0
TheFinalCD TheFinalCD 2 months ago
https://x.com/BPharmCatalyst/status/1846165983179718797
👍️0
Awl416 Awl416 2 months ago
RIP
👍️0
glenn1919 glenn1919 7 months ago
NTBL.................................https://stockcharts.com/h-sc/ui?s=NTBL&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 7 months ago
NTBL..........................................https://stockcharts.com/h-sc/ui?s=NTBL&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 8 months ago
Thanks for the heads up
👍️ 1
Eurotradr Eurotradr 8 months ago
NTBL AI presents cancer updates on Monday and Tuesday at AACR
👍️0
Monksdream Monksdream 9 months ago
NTBL under $2
👍️0

Your Recent History

Delayed Upgrade Clock